Header cover image

U.S. Healthtech Industry Analysis

UpdatedMay 28, 2022
DataAggregated Company Financials
Companies77
  • 7D5.5%
  • 3M-22.0%
  • 1Y-39.6%
  • YTD-36.4%

In the last week, the Healthtech industry is up 5.5%, with Veeva Systems leading the way, up 4.6%. In the same time, Biotricity was down 17%. In the past year, the industry is down 40%. As for the next few years, earnings are expected to grow by 34% per annum.

Industry Valuation and Performance

Has the U.S. Healthtech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Sat, 28 May 2022US$116.6bUS$23.2b-US$7,359,237,621.0049x
Mon, 25 Apr 2022US$131.2bUS$23.8b-US$823,593,303.0065.7x
Wed, 23 Mar 2022US$141.8bUS$23.9b-US$869,737,328.0083x
Fri, 18 Feb 2022US$152.4bUS$23.9b-US$1,703,521,715.0090.3x
Sun, 16 Jan 2022US$156.4bUS$23.7b-US$1,729,195,532.0092.6x
Tue, 14 Dec 2021US$168.9bUS$23.1b-US$1,291,880,240.0097.6x
Thu, 11 Nov 2021US$203.0bUS$22.9b-US$1,341,755,766.00113x
Sat, 09 Oct 2021US$188.8bUS$22.1b-US$1,254,921,150.00105.8x
Mon, 06 Sep 2021US$197.2bUS$21.9b-US$1,313,886,449.0492.8x
Wed, 04 Aug 2021US$188.7bUS$21.9b-US$1,229,889,348.3194.4x
Sat, 08 May 2021US$170.8bUS$20.3b-US$1,351,563,571.3193.6x
Tue, 09 Feb 2021US$188.6bUS$19.1b-US$2,269,608,711.3181.3x
Mon, 02 Nov 2020US$150.5bUS$17.5b-US$1,422,222,372.3192.6x
Thu, 06 Aug 2020US$110.7bUS$14.9b-US$1,221,765,849.3142.7x
Sun, 10 May 2020US$86.3bUS$14.2b-US$1,262,876,112.3144.3x
Sat, 01 Feb 2020US$73.5bUS$13.6b-US$316,037,126.3155.6x
Tue, 05 Nov 2019US$67.9bUS$13.4b-US$263,823,532.3148.5x
Fri, 09 Aug 2019US$74.5bUS$13.1b-US$85,430,019.3150x
Median PE Ratio

49.3x


Total Market Cap: US$66.3bTotal Earnings: US$614.2mTotal Revenue: US$12.5bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Healthtech Industry Median PE3Y Average 71.2x202020212022
Current Industry PE
  • Investors are more pessimistic on the industry, indicating that they anticipate long-term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 49.0x which is lower than its 3-year average PE of 71.2x.
Past Earnings Growth
  • Total earnings for the Health Care Technology industry have declined over the last three years, with the industry now making a loss overall.
  • Meanwhile revenues have grown 23% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does U.S. Healthtech compare with similar industries?

US Market5.92%
Healthcare1.80%
Healthtech5.47%
Healthtech5.47%
Industry PEThere is insufficient data on the sub-industries of this industry.
Forecasted GrowthThere is insufficient data on the sub-industries of this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
VEEV Veeva SystemsUS$172.004.6%
+US$1.2b
-41.0%PS62.3x
NUTX Nutex HealthUS$10.0021.2%
+US$1.1b
n/aPS40.9x
DOCS DoximityUS$35.3912.1%
+US$732.7m
n/aPS50.8x
TDOC Teladoc HealthUS$35.779.3%
+US$488.4m
-76.2%PS2.7x
MPLN MultiPlanUS$5.3813.3%
+US$402.6m
-36.3%PS34.3x
Simply Wall St
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

NH

US$0.53

NantHealth

7D

-10.7%

1Y

-79.8%

AUGX

US$2.11

Augmedix

7D

-11.7%

1Y

-64.8%